Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

HERBASEDAN CAPSULAS DURAS - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/HERBASEDAN CAPSULAS DURAS

Approved

STANDARD

HERBASEDAN CAPSULAS DURAS

Natysal S.A.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Feb 9, 2021
Approval ID: 1b4754de1cccda1b
Company: Natysal S.A.
Type: Standard

Approval Details

Approval Id: 1b4754de1cccda1b
Drug Cima Aemps Name: HERBASEDAN CAPSULAS DURAS
Register Number: 85753
Holder Company Name: Natysal S.A.
Marketing Company Name: Natysal S.A.
Authorization Date: 2021-02-09
Dosage Form: CÁPSULA DURA
Dose: 300 mg
Route Of Administration: VÍA ORAL
Prescription Type: Sin Receta
Commercialized: No
Company Name: Natysal S.A.

Active Ingredients

VALERIANA EXTRACTO HIDROALCOHOLICO SECO

300 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Feb 9, 2021

Approval ID

1b4754de1cccda1b

Type

Standard

Back to CIMA-AEMPS Approvals